Public procurement notice: Contract Award Notice
Published: 2019-09-11
Buyer: NHS Commissioning Board (operating under the name of NHS England)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value: 503860674 GBP
Award criteria: The most economic tender

Technical requirements: NHS Framework for the NHS London Region, Branded Medicines – Tranche B, Cytokine Modulators and Other Monoclonal Antibodies and Antiretrovirals
CM/PHR/16/5515/01 — 1.9.2019 to 31.8.2021 – NHS Framework for the NHS London Region, Branded Medicines – Tranche B with an option to extend (at the authority’s discretion) for a period or periods up to a total of 24 months.
CM/PHR/16/5515/02 — 1.9.2019 to 31.8.2020 — NHS Framework for the NHS London Region, Branded Medicines – Annual Tranche — Cytokine Modulators and other monoclonal antibodies with an option to extend (at the authority’s discretion) for a period or periods up to a total of 12 months.
CM/PHR/16/5515/03 — 1.9.2019 to 31.8.2020 – NHS Framework for the NHS London Region, Branded Medicines — Antiretrovirals with an option to extend (at the authority’s discretion) for a period or periods up to a total of 12 months.
NHS Framework for the NHS London Region, Branded Medicines – Tranche B with an Option to extend (at the Authority’s Discretion) for a Period or Periods Up to a Total of 24 Months
CM/PHR/16/5515/01 — 1.9.2019 to 31.8.2021 – NHS Framework for the NHS London Region, Branded Medicines – Tranche B with an option to extend (at the authority’s discretion) for a period or periods up to a total of 24 months.
Each individual National product code (NPC) pack description in each of the regions (London) is deemed to be a separate product for the application of the award criteria.
The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England.
The framework may also be used by private sector contractors and agents working on behalf of the above.
NHS Framework for the NHS London Region, Branded Medicines – Annual Tranche — Cytokine Modulators and Other Monoclonal Antibodies with an Option to extend (at the Authority’s Discretion) for a Period
CM/PHR/16/5515/02 — 1.9.2019 to 31.8.2020 — NHS Framework for the NHS London Region, Branded Medicines – Annual Tranche — Cytokine Modulators and other monoclonal antibodies with an option to extend (at the authority’s discretion) for a period or periods up to a total of 12 months.
Each individual National product code (NPC) pack description in each of the regions (London) is deemed to be a separate product for the application of the award criteria.
The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England.
The framework may also be used by private sector contractors and agents working on behalf of the above.
NHS Framework for the NHS London Region, Branded Medicines — Antiretrovirals with an Option to extend (at the Authority’s Discretion) for a Period or Periods Up to a total of 12 Months


Winner: NHS Comissioning Boards (Operating under the name of NHS England)
Award value: 503860674
Number of bids: 33